Find the Perfect Plan for Your Investment Journey
A
Latest price
52 Week Range
CA$0.03 - CA$0.03
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$8.75M |
EV | CA$29.85M |
Shares Outstanding | 349.88M |
Beta | 0.22 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2023E | - |
P/Revenue 2023E | - |
Revenue | 318.00% |
EPS | -53.50% |
Operating Cash Flow | -71.60% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2023E | - |
Net Profit Margin 2023E | - |
ROE 2023E | - |
ROCE 2022 | -114.48% |
DPS 2023E | - |
Payout Ratio 2023E | - |
Div. Yield 2023E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Australis Capital Inc.
AUSA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Booth, Terrance
Employees
Website
www.ausacap.comIPO Date
2018-09-19
Headquarters
376 East Warm Springs Road, Suite 190, Las Vegas, Nevada, 89119, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved